Ludwig Institute for Cancer Research and Polaris Group Form Collaboration to...
NEW YORK and SAN DIEGO, May 18, 2011 /PRNewswire/ — Ludwig Institute for Cancer Research LTD (LICR) and Polaris Group (Polaris) today announced the formation of a collaboration to expand development of...
View ArticlePfizer Drug Wins OK for Jobs’s Type of Cancer
Pfizer Inc. (PFE) won U.S. approval to expand marketing of a cancer drug for patients with the rare type of pancreatic tumor diagnosed in Apple Inc. (AAPL)’s Steve Jobs in 2004. The Food and Drug...
View ArticleThe Truth About the Drug Companies
July 15, 2004 Marcia Angell Every day Americans are subjected to a barrage of advertising by the pharmaceutical industry. Mixed in with the pitches for a particular drug—usually featuring beautiful...
View ArticleBig Pharma and marijuana
(NaturalNews) As DEA raids and IRS harassment continue on state-approved medical marijuana, Big Pharma eyes the profitability of cannabis and prepares to muscle in, using its lobbyists and government...
View ArticleFDA Strangling Consumer Health
6 November 2003 by Wyn Snow, Managing Editor Skyrocketing public health costs are bankrupting individual Americans and posing serious challenges to city, state, and federal budgets. The high cost of...
View ArticleObscene Profits Over Human Life
Life Extension Magazine June 2011 How the Government Helped Pfizer Make Millions While Breaking the Law As discussed in this month’s “As We See It,” the information contained in the following online...
View ArticleGenentech Scoops Up Tumor-Starving Drug Program From Forma Therapeutics In...
Luke Timmerman 6/27/11 Genentech doesn’t acquire many drugs from other people, partly because it has a prolific internal R&D operation. But the South San Francisco-based unit of Roche, the world’s...
View ArticleThe Great Cancer Hoax Part II: The Brilliant Cure the FDA Tried Their Best to...
Posted By Dr. Mercola | September 19 2011 | 264,550 views In 1971, US President Richard Nixon declared war on cancer; the National Cancer Act was enacted and the national cancer program was born. An...
View ArticleUK Regulator Gives Takeda Bone Cancer Drug (Mifamurtide) Final Backing
By Sten Stovall Published October 25, 2011 | Dow Jones Newswires Published October 25, 2011 | Dow Jones Newswires LONDON -(Dow Jones)- Takeda Pharmaceutical Co.’s (4502.TO) drug mifamurtide has secured...
View ArticleZIOPHARM Presents Promising Preclinical Pediatric Sarcoma Data with Oral and...
press release Oct. 28, 2011, 12:55 p.m. EDT NEW YORK, Oct 28, 2011 (BUSINESS WIRE) — ZIOPHARM Oncology, Inc. ZIOP -6.80% , a drug development company employing small molecule and synthetic biology...
View Article
More Pages to Explore .....